Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Jun;71(6):4254-63.
doi: 10.1128/JVI.71.6.4254-4263.1997.

The antiretrovirus drug 3'-azido-3'-deoxythymidine increases the retrovirus mutation rate

J G Julias  1 , T Kim, G Arnold, V K Pathak
Affiliations

The antiretrovirus drug 3'-azido-3'-deoxythymidine increases the retrovirus mutation rate

J G Julias et al. J Virol. 1997 Jun.

Abstract

It was previously observed that the nucleoside analog 5-azacytidine increased the spleen necrosis virus (SNV) mutation rate 13-fold in one cycle of retrovirus replication (V. K. Pathak and H. M. Temin, J. Virol. 66:3093-3100, 1992). Based on this observation, we hypothesized that nucleoside analogs used as antiviral drugs may also increase retrovirus mutation rates. We sought to determine if 3'-azido-3'-deoxythymidine (AZT), the primary treatment for human immunodeficiency virus type 1 (HIV-1) infection, increases the retrovirus mutation rate. Two assays were used to determine the effects of AZT on retrovirus mutation rates. The strategy of the first assay involved measuring the in vivo rate of inactivation of the lacZ gene in one replication cycle of SNV- and murine leukemia virus-based retroviral vectors. We observed 7- and 10-fold increases in the SNV mutant frequency following treatment of target cells with 0.1 and 0.5 microM AZT, respectively. The murine leukemia virus mutant frequency increased two- and threefold following treatment of target cells with 0.5 and 1.0 microM AZT, respectively. The second assay used an SNV-based shuttle vector containing the lacZ alpha gene. Proviruses were recovered as plasmids in Escherichia coli, and the rate of inactivation of lacZ alpha was measured. The results indicated that treatment of target cells increased the overall mutation rate two- to threefold. DNA sequence analysis of mutant proviruses indicated that AZT increased both the deletion and substitution rates. These results suggest that AZT treatment of HIV-1 infection may increase the degree of viral variation and alter virus evolution or pathogenesis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Virol. 1992 Dec;66(12):7128-35 - PubMed
    1. J Virol. 1996 Nov;70(11):7594-602 - PubMed
    1. Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5653-6 - PubMed
    1. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):6900-3 - PubMed
    1. J Virol. 1993 Sep;67(9):5623-34 - PubMed

Publication types

MeSH terms

LinkOut - more resources